Navigation Links
ALS Therapy Development Institute and Anida Pharma Partner to Investigate Potential Treatments for ALS
Date:9/10/2013

CAMBRIDGE, Mass., Sept. 10, 2013 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it has entered into a research partnership with Anida Pharma, Inc., to investigate a potential treatment for ALS, also known as Lou Gehrig's disease.   

(Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO)

Under the terms of the agreement with Anida, ALS TDI will test their lead compound, Neuroprotectin D1 (NPD1), in SOD1 mice for functional benefit.  NPD1, also referred to as Protectin D1 (PD1), activates resolution circuits to control neuroinflammation and prevent cell death, but also has trophic effects. To date, ALS TDI has conducted preclinical proof of concept studies with NPD1 in SOD1 mice. Through these pharmacodynamic studies, ALS TDI has demonstrated that it can deliver pharmacologically active levels of NPD1 to the central nervous system of the SOD1 mice, providing sufficient evidence to move it forward for additional preclinical testing.

"This partnership is yet another example of how our Institute, which is quite literally led by ALS patients and their families, identifies opportunities that otherwise may not get evaluated as a potential treatment for ALS," says Steve Perrin, Ph.D., CEO and CSO of ALS TDI. "It really is about moving as quickly as possible for patients today, and we are committed to doing just that through this partnership with Anida and the more than two dozen other programs our experienced drug development team is simultaneously working on at the Institute."

Anida marks the 12th venture philanthropy investment ALS TDI has made. Since 2007, ALS TDI has made more than $5 million of ventur
'/>"/>

SOURCE ALS Therapy Development Institute
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
3. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
6. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
7. BHI Raises Awareness of Hearing Aids as Potential Therapy to Help Quiet "Ringing in the Ears" During National Tinnitus Awareness Week
8. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
9. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
10. Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
11. The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  Depomed, Inc. (NASDAQ: ... that its Board of Directors, after careful consideration ... and legal advisors, has unanimously rejected the purported ... Horizon Pharma plc (NASDAQ: HZNP ) ("Horizon") ... Depomed in an all-stock transaction (the "July 21 ...
(Date:7/29/2015)... 29, 2015 The U.S. Food and Drug ... the ReShape Integrated Dual Balloon System, that may help ... people with obesity and one or more obesity-related conditions, ... Surgery (ASMBS), the nation,s largest organization for bariatric surgeons. ... careful review the FDA has approved this new device ...
(Date:7/29/2015)... SAN DIEGO and WALTHAM, Mass., July 29, ... LLP is investigating whether certain officers ... breached their fiduciary duties to shareholders.  AMAG Pharmaceuticals ... on maternal health, anemia, and cancer supportive care.  ... to reduce the risk of preterm birth in ...
Breaking Medicine Technology:Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2
... 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: ... biotechnology company focused on researching, developing, manufacturing and ... general meeting of shareholders of 3SBio Inc. will ... a.m., Shenyang time, at our executive office, 15/A-D, ...
... U.S. Food and Drug Administration today approved Adcetris (brentuximab ... lymphoma known as systemic anaplastic large cell lymphoma (ALCL). ... cancers of the lymphatic system. Adcetris is an antibody-drug ... antibody to direct the drug to a target on ...
Cached Medicine Technology:3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011 2FDA Approves Adcetris to Treat Two Types of Lymphoma 2FDA Approves Adcetris to Treat Two Types of Lymphoma 3
(Date:7/29/2015)... , ... July 29, 2015 , ... ... that seek to help with the problems of substance abuse that face today’s ... Drunk Driving (MADD) to come to their rehabilitation center. The facility, located in ...
(Date:7/29/2015)... ... 29, 2015 , ... Conventional theories used by economists for the past 150 ... able to unlock mysteries about the behavior of microbial life on earth, according to ... University. , The findings, published July 29 in the open access journal PLOS ONE, ...
(Date:7/29/2015)... ... 29, 2015 , ... VideoLink , a leading provider ... in New York, NY, selected the ReadyCam on-site video studio to support their ... immediately access worldwide TV and cable news networks and participate in live TV ...
(Date:7/29/2015)... ... July 29, 2015 , ... Abt Associates has named Selena ... division. In her position, Ramkeesoon will help build and expand work in ... spent close to a decade at ICF International, most recently as a vice ...
(Date:7/29/2015)... ... July 29, 2015 , ... Andrzej Klos, M.D., has been reviewed and approved ... nearly 38 years, is motivated each and every day by his sincere desire to ... alongside his many awards and accolades, which include multiple listings in many highly regarded ...
Breaking Medicine News(10 mins):Health News:MADD Victim Services Specialist Visits A Forever Recovery Rehabilitation Facility 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:Selena Ramkeesoon Joins Abt Associates as Vice President for Strategic Communications 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3
... Sept. 2 (HealthDay News) -- Having weight loss surgery before ... have both procedures, according to a small new study. ... first -- including reduced pain and increased ability to exercise ... breasts after they lose large amounts of weight, Dr. Jeffrey ...
... -- A rapid rise in hookah use in California is cause ... used for smoking tobacco. An analysis of state data showed that ... 40 percent between 2005 and 2008. In 2008, hookah use ... percent of men, 10 percent of women) than it was among ...
... (HealthDay News) -- Children,s social goals help determine how ... are effective, researchers say. The new study included ... respond to other students, aggression, how often they were ... created three categories of social goals: wanting to gain ...
... students who practiced on a patient simulator before assisting ... final examinations than did students receiving a lecture only ... of the University of South Florida randomized, controlled trial ... journal Obstetrics & Gynecology. The USF ...
... FRIDAY, Sept. 2 (HealthDay News) -- At age 36, Charles Ruma ... home builder. His diagnosis with testicular cancer came as a shock. ... the older population," Ruma said. "I felt healthy and strong and ... hear those words." , , During his recovery from surgery ...
... , FRIDAY, Sept. 2 (HealthDay News) -- College ... maintaining a healthy lifestyle from day one, an expert says. ... is a great opportunity to establish a healthy lifestyle that ... of medicine at Quinnipiac University School of Medicine in Hamden, ...
Cached Medicine News:Health News:Is Breast Reduction After Weight Loss Surgery Best? 2Health News:Hookah Use Growing Among Young Adults in California 2Health News:Some Kids Seem to Cope Better With Bullying 2Health News:Simulation training in obstetric clerkship improves medical students' examination scores 2Health News:Simulation training in obstetric clerkship improves medical students' examination scores 3Health News:Survivor Builds 'Cancer-Fighting' House 2Health News:Survivor Builds 'Cancer-Fighting' House 3
For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl...
For the quantitative determination of direct & total bilirubin in serum. Modified Malloy-Evelyn Diazotization Method. Endpoint Reaction Product measured at 540 nm. Linearity: 20 mg/dl...
... first microplate spectrophotometer designed specifically to run ... week. With rugged hardware, proven optical performance ... barrier of traditional spectrophotometry to obtain results ... easily read up to eight, 1 cm ...
... 1100RS Spectrophotometers are simple, ... for use in many ... educational, clinical, industrial and ... COD vial holders, Windows ...
Medicine Products: